Clinical Trial Update: A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating rituximab in combination with bevacizumab in patients with follicular lymphoma; results have been posted after study completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Avastin (bevacizumab)
• Rituxan (rituximab)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Lymphoma, Follicular | Phase 2 | Status: COMPLETED | Results posted: 2014-12-12